ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0617

Concerns and Beliefs About COVID-19 Vaccination Among Racial and Ethnic Minority Patients with Rheumatic Disease

Maria I. Danila, Lesley Jackson, Amy Mudano, Giovanna Rosas, Jeanne Merchant, Jeffrey Foster and Kenneth Saag, University of Alabama at Birmingham, Birmingham, AL

Meeting: ACR Convergence 2021

Keywords: Access to care, autoimmune diseases, COVID-19, Epidemiology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Healthcare Disparities in Rheumatology Poster (0594–0622)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Alabama lags behind many other states in COVID-19 vaccination uptake and racial/ethnic minority groups face COVID-19 vaccine access disparities. Moreover, lack of vaccination access and medical mistrust among Alabama’s large African American population, a vestige of the devastating Tuskegee Syphilis study, further perpetuate health care disparities. We examined concerns and beliefs about COVID-19 vaccination among racial and ethnic minority patients receiving rheumatology care at a large academic medical center in the Deep South and factors associated with COVID-19 vaccine receipt.

Methods: In April 2021, we invited racial and ethnic minority patients to complete a survey on a tablet computer during an in-person visit to the rheumatology clinics at our center. Vaccination confidence was assessed using the confidence scale from the validated 5C psychological antecedents of vaccination. Descriptive statistics summarized attitudes and beliefs about COVID-19 vaccination and multivariable logistic regression determined factors associated with receipt of a COVID-19 vaccine. The following factors were examined: age, sex, education, vaccine confidence, safety concerns, medical mistrust, past flu vaccine receipt.

Results: Of the 156 racial and ethnic minority patients approached between April 19 and May 6, 2021, 150 agreed to complete the survey. Mean (standard deviation) for age was 54 (15.9) years, 86.9% were women, 94% identified themselves as Black or African American, 69% had at least some college, and 22% said they believed they would have gotten better medical care if they belonged to a different race or ethnic group (Table 1). Although 81% of respondents reported prior receipt of flu vaccine, only two thirds reported having had the COVID-19 vaccine. Of those who were not yet vaccinated (N=50), half had been offered the vaccine and a third said they did not plan were to be vaccinated. The most common reasons for not getting vaccinated included concerns about side effects (56%), fear of disease flare (53%), knowing someone who had a bad experience with the vaccine (32%), concern of getting COVID-19 from the vaccine (21%), and concern that the vaccine would “modify my DNA” (18%). Those not yet vaccinated expressed a need to obtain information about the efficacy and safety of this vaccination in people with rheumatic disease. After multivariable adjustment, older age, not having safety concerns about COVID-19 vaccine, past flu vaccine receipt, and higher vaccine confidence were associated with COVID-19 vaccination (Table 2). There was no association between reporting medical mistrust and COVID-19 vaccine receipt.

Conclusion: During the COVID-19 vaccine roll out in Alabama, one in ten racial and ethnic minority patients in a large academic rheumatology clinic said they were unlikely to get vaccinated. Older age, past flu vaccine receipt, higher confidence in and lack of safety concerns about the COVID-19 vaccine were associated with COVID-19 vaccination. Our findings highlight the need for tailored COVID-19 vaccination programs for individuals with rheumatic diseases in these subpopulations susceptible to health disparities to help ensure individual and societal protection against COVID-19.

Table 1.

Table 2


Disclosures: M. Danila, Pfizer, 5, Pfizer, 11, AbbVie, 1, Amgen, 5, Amgen, 1, Boehringer Ingelheim, 5, Horizon, 5, WebMD, 12, writer, Novartis, 1; L. Jackson, None; A. Mudano, None; G. Rosas, None; J. Merchant, None; J. Foster, None; K. Saag, Arthrosi, 2, Atom Bioscience, 2, Horizon Therapeutics, 2, 5, LG Pharma, 2, Mallinkrodt, 2, SOBI, 2, 5, Takeda, 2, Shanton, 5.

To cite this abstract in AMA style:

Danila M, Jackson L, Mudano A, Rosas G, Merchant J, Foster J, Saag K. Concerns and Beliefs About COVID-19 Vaccination Among Racial and Ethnic Minority Patients with Rheumatic Disease [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/concerns-and-beliefs-about-covid-19-vaccination-among-racial-and-ethnic-minority-patients-with-rheumatic-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/concerns-and-beliefs-about-covid-19-vaccination-among-racial-and-ethnic-minority-patients-with-rheumatic-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology